Adlai Nortye Group ANL
$8.55 −$0.51 (-5.63%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $8.55 0.00%
Open$8.93
Prev close$9.06
Day range$8.36 – $9.11
Volume380.6K
Market cap$550.60M
P/E (TTM)–
Dividend yield–
ANL Stock News
Headlines matching Adlai Nortye Group or the ANL ticker, most recent first.
- H.C. Wainwright Maintains Adlai Nortye Group(ANL.US) With Buy Rating, Maintains Target Price $20
- Lucid Capital Initiates Adlai Nortye Group(ANL.US) With Buy Rating, Announces Target Price $49
- Jefferies Initiates Adlai Nortye Group(ANL.US) With Buy Rating, Announces Target Price $31
- Oppenheimer Maintains Adlai Nortye Group(ANL.US) With Buy Rating, Maintains Target Price $32
- Analysts Offer Insights on Healthcare Companies: Sysmex (OtherSSMXF) and Adlai Nortye Ltd. Sponsored ADR (ANL)
- Analysts' Opinions Are Mixed on These Healthcare Stocks: US Physical Therapy (USPH) and Adlai Nortye Ltd. Sponsored ADR (ANL)
- JonesTrading Maintains Adlai Nortye(ANL.US) With Buy Rating, Maintains Target Price $22
- H.C. Wainwright Maintains Adlai Nortye(ANL.US) With Buy Rating, Maintains Target Price $20
- JonesTrading Initiates Adlai Nortye(ANL.US) With Buy Rating, Announces Target Price $22
- Adlai Nortye Ltd. Sponsored ADR (ANL) Receives a Buy From Cantor Fitzgerald
- Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Harmony Biosciences Holdings (HRMY) and Adlai Nortye Ltd. Sponsored ADR (ANL)
- Analysts Offer Insights on Healthcare Companies: MetaVia (MTVA) and Adlai Nortye Ltd. Sponsored ADR (ANL)
- Cantor Fitzgerald Initiates Adlai Nortye(ANL.US) With Buy Rating, Announces Target Price $28
- Cantor Fitzgerald Initiates Adlai Nortye(ANL.US) With Buy Rating
- Oppenheimer Initiates Adlai Nortye(ANL.US) With Buy Rating, Announces Target Price $32
No comments yet — be the first to weigh in on ANL.
Sign in to join the discussion.